Dose Finding Study to Treat High Phosphate Levels in the Blood
A look at the following clinical trial: Dose Finding Study to Treat High Phosphate Levels in the Blood.
Hyperphosphatemia Clinical Trials
Safety and Tolerability Study of MCI-196
A look at the following clinical trial: Safety and Tolerability Study of MCI-196.
A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia
A look at the following clinical trial: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia.
A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
A look at the following clinical trial: A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia.
A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
A look at the following clinical trial: A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia.
A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia
A look at the following clinical trial: A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia.
Dose-finding Study of MCI-196
A look at the following clinical trial: Dose-finding Study of MCI-196.
A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
A look at the following clinical trial: A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
A look at the following clinical trial: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.
Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)
A look at the following clinical trial: Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD).
Want to read more?
Please login or register first to view this content.